Food And Drug Administration
The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is supported by science.
Heart-clogging trans fats were once a staple of the American diet, plentiful in baked goods, microwave popcorn and fried foods. Now, mindful of the health risks, the Food and Drug Administration is getting rid of what’s left of them for good.
The Food and Drug Administration is trying to solve a stubborn mystery surrounding the deaths of almost 600 dogs that ate jerky treats, and officials are hoping pet owners and veterinarians can help them figure out what exactly may be causing the illnesses.
Gilead Sciences said Monday that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the Foster Citry company’s manufacturing facilities.
Thousands of pet owners nationwide are furious that the treats they believe sickened or killed their pets are still on store shelves, and now a well-known congressman is calling for an investigation into the FDA’s handling of the issue.
Four Chinese plants that produce chicken jerky treats sold by American companies have refused to allow Federal Drug Administration investigators to take samples for analysis despite complaints from pet owners, according to an NBC report.
The Food and Drug Administration has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS.
The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.
First it was pink slime. Now a California legislator has asked the U.S. Department of Agriculture to investigate the potential dangers of steaks made with meat glue.
Drugmaker Vivus Inc. said Monday that regulators will take another three months to make a decision on its closely-watched obesity drug Qnexa.